Physician

Andrew E Huff, MD

According to 2025 Medicare claims, Andrew Huff, MD (NPI: 1285607747) practices anesthesiology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Pottawattamie, IA. This provider's primary affiliated billing organization is ORTHOWEST LLC (NPI: 1275641904; TIN: 470845955) and primary practice location at 51503-4643. Huff is affiliated with the Nebraska Health Network, LLC (ACO ID: A3273), NPG Health Collaborative LLC (ACO ID: A3287), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Maple ACO LLC (ACO ID: A5401), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Huff's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 377 traditional Medicare patients, billed 6,620 HCPCS/CPT codes, and received $203,200 in Medicare payments. The top billing code was 62323 (Injection of substance into lower spine canal using imaging guidance). Part D data shows 2,099 prescription claims across 394 beneficiaries totaling $77,619 in drug costs, led by Gabapentin (Gabapentin). 2022 DME data shows 11 claims. Open Payments data shows 46 records totaling $4,804. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $30,985 and ending at $77,619. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	488	5,681	$249,546
2016	371	4,811	$237,625
2017	464	4,148	$288,615
2018	469	3,318	$245,487
2019	461	4,037	$249,135
2020	379	2,407	$210,124
2021	415	2,994	$228,995
2022	415	3,452	$221,658
2023	428	4,398	$208,167
2024	377	6,620	$203,200

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	164	651	$30,985
2016	194	927	$54,292
2017	240	1,145	$62,070
2018	273	1,441	$71,096
2019	287	1,876	$97,645
2020	298	1,776	$70,048
2021	305	1,890	$53,280
2022	349	2,018	$81,749
2023	359	2,096	$68,654
2024	394	2,099	$77,619

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$551
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
62323	Injection of substance into lower spine canal using imaging guidance	80	95	$170
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	68	68	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	285	606	$57
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	68	80	$37
J1100	Injection, dexamethasone sodium phosphate, 1 mg	116	848	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gabapentin	Gabapentin	351	16,316	$6,981
Oxycodone Hcl	Oxycodone Hcl	203	5,020	$4,516
Pregabalin	Pregabalin	153	4,575	$4,502
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	236	3,977	$3,960
Tramadol Hcl	Tramadol Hcl	223	5,049	$2,849

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$4,804	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$74,737	Spinal Simplicity, LLC

Explore More Providers

FAQ

What Medicare data is available for Andrew E. Huff, MD?

Tedicare shows public-source Medicare data for Andrew E. Huff, MD (NPI 1285607747), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew E. Huff, MD have ACO affiliation data?

Andrew E. Huff, MD is shown with ACO affiliation data for Nebraska Health Network, LLC (MSSP, ACO ID A3273), NPG Health Collaborative LLC (MSSP, ACO ID A3287), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Maple ACO LLC (MSSP, ACO ID A5401), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Andrew E. Huff, MD?

Andrew E. Huff, MD is linked to ORTHOWEST LLC (billing NPI 1275641904) in the available physician profile data.

Does Andrew E. Huff, MD have Open Payments data?

Andrew E. Huff, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.